Laboratorios Farmaceuticos Rovi, S.A.'s latest marketcap:

About Laboratorios Farmaceuticos Rovi, S.A.

Laboratorios Farmaceuticos Rovi, S.A. is a pharmaceutical company specializing in the manufacturing, sale, and marketing of pharmaceutical products. Established in 1946 and headquartered in Madrid, Spain, the company operates globally, serving Spain, the European Union, OECD countries, and international markets.

Product Portfolio

Rovi offers a diverse range of pharmaceutical solutions across multiple therapeutic areas:

Prescription Products

• Cardiology & Endocrinology: Ameride, Prinvil, Neparvis
• Central Nervous System: Medicebran, Medikinet, Tryptizol
• Respiratory: Hirobriz Breezhaler, Ulunar Breezhaler
• Women's Health & Osteoarticular: Calcium Vitamine D3 Rovi, Bertanel
• Other Treatments: Rhodogil, Glufan, Mysimba, Orvatez

Hospital Products

• Diagnostic Imaging: Iomeron, Iopamiro, Multihance, Sonovue
• Catheter Care: Fibrilin
• Specialty Injectables: Sodium Heparin Rovi

Contract Manufacturing Services

Rovi provides comprehensive pharmaceutical manufacturing solutions, including:

• Compounding and aseptic filling
• Terminal sterilization and inspection
• Safety device installation and labeling
• Packaging, serialization, and aggregation

The company specializes in injectable forms (prefilled syringes, vials, cartridges) and solid dosage products.

Therapeutic Applications

Rovi's products serve multiple medical specialties:

• Cardiology
• Osteoarticular/Women's Health
• Anesthesia/Pain Management
• Diagnostic Imaging
• Central Nervous System
• Urology
• Endocrinology
• Respiratory
• Primary Healthcare

Parent Company: Norbel Inversiones, S.L.